Expiration date: 09/2025

Action:

combined agent (blocker of "slow" calcium channels + angiotensin converting enzyme inhibitors + HMG-Co-a-reductase inhibitor).

Composition:

Amlodipine+Lisinopril+Rosuvastatin

Indications:

primary hypercholesterolemia, family homozygous hypercholesterolemia, when diet or other lipid-lowering therapy (eg, LDL apheresis) is not effective, hypertriglyceridemia (type IV Fredrickson classification).